All Curated Mutation Sites in EBOV

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in EBOV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Keyword: VP35

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	18199658	R312A	VP35	VP35	Cell line Hemorrhagic fever, ebola	G I T	View
2	20071589	K319A	VP35	VP35	Cell line Hemorrhagic fever, ebola	G R T	View
3	20071589	R322A	VP35	VP35	Cell line Hemorrhagic fever, ebola	G R T	View
4	18353943	R312A	VP35	VP35	Cell line	G I T	View
5	16698997	K309A	VP35	VP35	Cell line	G T	View
6	16698997	R312A	VP35	VP35	Cell line	G T	View
7	19828757	R312A	VP35	VP35	Cell line	T	View
8	25142601	F239A	VP35	VP35	Cell line	G T	View
9	25142601	R322A	VP35	VP35	Cell line	G T	View
10	35533195	K309R	VP35	VP35	Cell line	I T	View
11	17065211	1_200del	VP35	VP35	Cell line	G I	View
12	17065211	R312A	VP35	VP35	Cell line	G I	View
13	24495995	I295A	VP35	VP35	Cell line		View
14	24495995	K248A	VP35	VP35	Cell line		View
15	20516601	K319A	VP35	VP35	Cell line	G R	View
16	20516601	K339A	VP35	VP35	Cell line	G R	View
17	20516601	R312A	VP35	VP35	Cell line	G R	View
18	20516601	R322A	VP35	VP35	Cell line	G R	View
19	22289166	K309A	VP35	VP35	Cell line	G	View
20	22289166	R305A	VP35	VP35	Cell line	G	View
21	22289166	R312A	VP35	VP35	Cell line	G	View
22	33028676	G4056A	VP35	VP35	Cell line	G R S	View
23	33028676	S310N	VP35	VP35	Cell line	G R S	View
24	31694758	S129A	VP35	VP35	Cell line		View
25	31694758	S187A	VP35	VP35	Cell line		View
26	31694758	S187D	VP35	VP35	Cell line		View
27	31694758	S205A	VP35	VP35	Cell line		View
28	31694758	S205D	VP35	VP35	Cell line		View
29	31694758	S208A	VP35	VP35	Cell line		View
30	31694758	S208D	VP35	VP35	Cell line		View
31	31694758	S317A	VP35	VP35	Cell line		View
32	31694758	S317D	VP35	VP35	Cell line		View
33	31694758	T206A	VP35	VP35	Cell line		View
34	31694758	T206D	VP35	VP35	Cell line		View
35	25972536	R312A	VP35	VP35	Cell line		View
36	30524754	A4397G	VP35	VP35	Cell line	R	View
37	35533195	K309G	VP35	VP35	Cell line		View
38	27009368	S26T	VP35	VP35		G T	View
39	27009368	A290V	VP35	VP35		G	View
40	27009368	E269D	VP35	VP35		G	View
41	27009368	E48D	VP35	VP35		G	View
42	26466951	I295A	VP35	VP35			View
43	26466951	K248A	VP35	VP35			View
44	26466951	K251A	VP35	VP35			View
45	28110448	I295A	VP35	VP35			View
46	28110448	K248A	VP35	VP35			View
47	28205249	K339A	VP35	VP35			View
48	28205249	R312A	VP35	VP35			View
49	28205249	R322A	VP35	VP35			View
50	28298161	I29D	VP35	VP35			View
51	28298161	L33D	VP35	VP35			View
52	28298161	M34P	VP35	VP35			View

Contents
Description

The table shows all curated mutation sites of EBOV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.